QRX003 clinical trials

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

This study is testing a new lotion, QRX003, for people with Netherton Syndrome. It aims to see if the lotion is safe, well-tolerated, and helps improve skin affected by the condition. It's for people aged 4 and older, applied twice daily for 12 weeks to affected skin.